Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Maastricht University Medical Center
Maastricht University Medical Center
British Columbia Cancer Agency
Exelixis
Medical College of Wisconsin
Genentech, Inc.
University Medical Center Groningen
University of California, San Francisco
Centre Georges Francois Leclerc
Centre Leon Berard
Fate Therapeutics
Fate Therapeutics
Jules Bordet Institute
Oncovir, Inc.
Celldex Therapeutics